Gene therapy Books
Icon Books Hacking the Code of Life: How gene editing will
Book Synopsis'An excellent, brisk guide to what is likely to happen as opposed to the fantastically remote.' - Los Angeles Review of BooksIn 2018 the world woke up to gene editing with a storm of controversy over twin girls born in China with genetic changes deliberately introduced by scientists - changes they will pass on to their own offspring. Genetic modification (GM) has been with us for 45 years now, but the new system known as CRISPR or gene editing can manipulate the genes of almost any organism with a degree of precision, ease and speed that we could only dream of ten years ago. But is it ethical to change the genetic material of organisms in a way that might be passed on to future generations? If a person is suffering from a lethal genetic disease, is it unethical to deny them this option? Who controls the application of this technology, when it makes 'biohacking' - perhaps of one's own genome - a real possibility?Nessa Carey's book is a thrilling and timely snapshot of a cutting-edge technology that will radically alter our futures and the way we prevent disease.'A focused snapshot of a brave new world.' - Nature 'A brisk, accessible primer on the fast-moving field, a clear-eyed look at a technology that is already driving major scientific advances - and raising complex ethical questions.' - Emily Anthes, UndarkTrade ReviewCarey's trawl of potential applications - such as high-yield rice varieties, therapies for sickle-cell disease and germline gene editing - is edifying. A focused snapshot of a brave new world. * Nature *[A]n excellent, brisk guide to what is likely to happen as opposed to the fantastically remote. * Los Angeles Review of Books *A brisk, accessible primer on the fast-moving field, a clear-eyed look at a technology that is already driving major scientific advances - and raising complex ethical questions. -- Emily Anthes * Undark *
£8.24
John Wiley & Sons Inc Integration of Biomaterials for Gene Therapy
Book SynopsisINTEGRATION OF BIOMATERIALS FOR GENE THERAPY Brings industrial practitioners and researchers together to discuss how the deeper integration of biomaterial platforms could play a significant role in enabling breakthroughs in the application of gene editing for the treatment of human disease. This book comprises research and review articles from leading researchers with multidisciplinary experience. It discusses many broad topics, including nanoparticle-enabled gene therapy, inorganic nanocarrier-based gene delivery, non-viral delivery of nucleic acid, biocompatible hydrogels, silk, and polysaccharides-based gene delivery. Other gene delivery topics discussed include the use of smart and engineered biomaterials, combined therapy with growth factors and cell transportation, and the prospects and challenges in the treatment of different diseases, including cancer. This book bridges the knowledge of pharmaceutics, engineering, basic science, and clinical research fields in a way that will hTable of ContentsForeword xvii Preface xix Acknowledgment xxi 1 Biocompatible Hydrogels for Gene Therapy: Advancement and Applications 1Ankita Gupta and Swatantra K.S. Kushwaha 1.1 Introduction 2 1.2 Hydrogels Classification 3 1.3 Fabrication of Hydrogels and Its Desirable Technical Features 4 1.4 Factors to be Tuned for Gene Encapsulation in Hydrogels 4 1.5 Recent Advances on Hydrogels for Gene Delivery 6 1.6 Conclusion 9 2 Use of Polysaccharides: Novel Delivery System for Genetic Material 13Prashant Kumar, Swatantra K.S. Kushwaha, Neelottama Kushwaha, Abhishek Singh and Surya Nath Pandey 2.1 Introduction 14 2.2 Cross-Linking Techniques for Engineering Polysaccharides-Based Biomaterials 23 2.3 Approaches to Design Polysaccharide-Derived Biomaterials 26 2.4 Biomedical Applications of Polysaccharide-Derived Biomaterials 29 2.5 Advanced Biomaterials for Wound Dressings 30 2.6 Scaffolds for Tissue Engineering and Development of Bioinks for 3D Bioprinting 30 2.7 Recent Utilization of Polysaccharides 31 2.8 Toxicity Concerns of Polysaccharide-Derived Biomaterials 33 2.9 Preclinical and Clinical Studies on Gene Delivery Using Polysaccharide-Based Biomaterials 33 2.10 Challenges and Future Directions 34 2.11 Future Prospects 35 2.12 Conclusion 35 3 Polysaccharide-Based Biomaterials for Gene Delivery 47Ankita Moharana, Abhitav Tiwari, Shalini Perada, Shivlal Yadav and Om Prakash Kumar 3.1 Background 48 3.2 Introduction 49 3.3 Gene Therapy 51 3.4 Gene Delivery Systems Based on Polysaccharides 53 3.5 Practical Application of Gene Delivery Systems 56 3.6 Polysaccharide-Based Nanoparticles 57 3.7 DNA Delivery 63 3.7.1 siRNA Delivery 65 3.8 Conclusion 70 4 Hydrogel-Based Gene Therapy 77Shweta Kumari, Dipti Jena, Vedant Kumar Prajapati, Shashi Ranjan Singh and Garima Tripathi 4.1 Introduction 78 4.2 Gene Therapy 83 4.3 In Vivo Gene Therapy Using Hydrogels 86 4.4 Encapsulating Cells in Hydrogels for Gene Therapy Delivery 87 4.5 Hydrogels for Integrative Tissue Engineering and Cell Delivery 89 4.6 Biocompatible Hydrogels for Transferring Cells 91 4.7 Using Hydrogels for Gene Therapy in Tissue Engineering-Based Drug 93 4.8 Human Gene Therapy that Uses Hydrogel as an Alternative Method of Delivering Genetic Material to Patients 94 4.9 Recent Advancement in Biocompatible Hydrogel 96 4.10 Applications of Hydrogel 99 4.11 Current Hydrogels in Clinical Trials 104 4.12 Conclusions 106 5 Progress and Prospects for Non-Viral Gene Therapy 117Shashimala Tiwari 5.1 Introduction 118 5.2 Definition 118 5.3 Technology Overview for Non-Viral Gene Delivery 119 5.4 Chemical Carriers for Gene Transfer: Establishing Effective In Vivo Gene Delivery 121 5.5 Types of Gene Delivery 122 5.6 Reduction of Immunological Responses Through Alteration of Delivery Method or DNA Structure 124 5.7 To Enable Long-Lasting Gene Expression, Self-Replicating, Tissue-Specific, and Integrating Plasmid Expression Systems are Designed 124 5.8 Hybrid Vector Systems to Improve Transfection and Lessen Cytotoxicity 125 5.9 Vehicle Material 127 5.10 Further Effects 129 5.11 Challenges and Prospects 130 5.12 Conclusion 132 6 Nanoparticles for Tumor Gene Therapy: Recent Advances and Perspective 139R. Shivhare, V. Sabale, A. Ingole and Neelam Jain 6.1 Introduction 140 6.2 Technologies for Gene Delivery 142 6.3 Cancer Treatment with Gene Therapy 147 6.4 Gene Therapy Using Nanotechnology 147 6.5 Challenges and Future Aspects 160 7 Effective Gene Transfer with Non-Viral Vectors 183Anil Kumar Mavi, Sonal Gaur, Neelesh Kumar, Avanish Kumar Shrivastav, Sankha Bhattacharya,Sateesh Belemkar, Saurabh Maru and Dhruv Kumar 7.1 Introduction 184 7.2 System Development for Delivering Genes 186 7.3 Methods for Non-Viral Vector for Delivery of Genes 186 7.4 Delivery System 203 7.5 Current Methods for Nonviral Gene Delivery: Benefits and Drawbacks 209 7.6 Current Barriers for Non-Viral Vectors 210 7.7 Possibilities for Enhancing the Non-Viral Vector Delivery System 212 7.8 Conclusion 212 7.9 Future Relevance 213 8 Utilization of Chitosan for Gene Delivery 223Johnson Olaleye Oladele 8.1 Introduction 224 8.2 Cationic Polymers-Based Gene Delivery Systems 225 8.3 Chitosan and Its Derivatives in Gene Delivery Systems 228 8.4 Chitosan as Chemotherapeutic Drugs 234 8.5 Conclusion 236 9 Nanoparticles as Gene Vectors in Tumor Therapy 247 Efstathia Triantafyllopoulou, Orestis Kontogiannis, Nefeli Lagopati, Natassa Pippa and Maria Gazouli 9.1 Introduction 248 9.2 Polymer-Based Nanocarriers: Their Technology and Recent Advances 249 9.3 Conclusions 271 10 Progress in Non-Viral Delivery of Nucleic Acid: Advancement in Biomedical Technology 281Anil Kumar Mavi, Manmohan Kumar, Amarjeet Singh, Mahendra Kumar Prajapati, Rakhi Khabiya, Saurabh Maru and Dhruv Kumar 10.1 Introduction 282 10.2 Physical Methods of Non-Viral Nucleic Acid Delivery System 285 10.3 Advantages and Disadvantages of Physical Transfection 296 10.4 Chemical Methods of Non-Viral Nucleic Acid Delivery System 296 10.5 Advantages and Disadvantages of Chemical Transfection 308 10.6 Cellular Barriers for Nucleic Acid Delivery Faced by Non-Viral Vectors 309 10.7 Challenges and Limitations of Non-Viral Nucleic Acid Delivery System 311 10.8 Conclusion 311 11 The Junction of Biomaterials and Gene Therapy -- Current Strategies and Future Directions 323Ranjan Kumar Singh, Sunita Panchawat, Chennu M.M. Prasada Rao, Joohee Pradhan, Rajeswari Tanniru, Deepika Bairagee and Ajay Kumar Garg 11.1 Introduction 324 11.2 Viral Gene Therapy 327 11.3.1 Adenoviral Vectors 329 11.4 Adeno-Associated Viral Vectors 330 11.5 Non-Viral Gene Therapy 331 11.6 Recent Advances in the Development of Gene Delivery Systems 334 11.7 Development of Gene Delivery Systems 335 11.8 Viral Vectors Based on DNA for Gene Delivery Systems 336 11.9 Viral Vectors Based on RNA for Gene Delivery Systems 337 11.10 Oncolytic Viral Vectors for Gene Delivery Systems 337 11.11 Practical Application of Gene Delivery Methods 343 11.12 Conclusion 347 12 Utilization of Silk for Gene Delivery 349Swatantra K. S. Kushwaha, Shruti Khare and Neelottama Kushwaha 12.1 Introduction 350 12.2 Dimensional Structure of Silk 350 12.3 Properties of Silk 351 12.4 Extraction of Fibroin from Silk Worm 352 12.5 Fabrication of Silk in Different Therapeutics Carriers 353 12.6 Utilization of Silk for Gene Therapy 354 12.7 Properties of Silk Fibroin as Biomaterial 355 12.8 Summary of Silk-Based Formulations for Gene Delivery 357 12.9 Examples of Some Delivery Approaches which Utilizes Silk as a Biomaterial for Gene Delivery 358 12.10 Some Highlights of Silk Fibroin 360 12.11 Conclusion 360 13 Challenges and Emerging Problems in Nanomedicine Mediated Gene Therapy 367Shalini Bhatt, Neha Faridi, Rakshit Pathak, Vinay Deep Punetha and Mayank Punetha 13.1 Introduction 368 13.2 Why Nanomedicine Over Traditional Drugs? 369 13.3 Nanomedicine for Gene Therapy 373 13.4 Complications in Nanomedicine-Mediated Gene Therapy 384 13.5 Challenges in the Clinical Translation of Nanomedicines 391 13.6 Conclusion 396 14 Biomaterials-Based Vaccination in Cancer Therapy 417Rishav Sharma, Rishabha Malviya and Sonali Sundram 14.1 Introduction 417 14.2 Tumor-Associated Antigens 418 14.3 Vaccine Delivery 419 14.4 Dendritic Cells 420 14.5 In Vitro Generation of Dendritic Cells 421 14.6 Usage of RNA 422 14.7 RNA-Pulsed DCs as Vaccines 422 14.8 RNA Vaccines 425 14.9 Optimization of Immunotherapy 426 14.10 Cancer Treatment Through RNA Interference 427 14.11 Conclusion 428 References 429 Index 435
£153.00
Nova Science Publishers Inc Trends in Gene Therapy Research
Book Synopsis
£129.74
Nova Science Publishers Inc Stem Cell Therapy
Book SynopsisAmong the many applications of stem cell research are nervous system diseases, diabetes, heart disease, auto-immune diseases as well as Parkinson''s disease, end-stage kidney disease, liver failure, cancer, spinal cord injury, multiple sclerosis, Parkinson''s disease, and Alzheimer''s disease. Stem cells are self-renewing, unspecialised cells that can give rise to multiple types all of specialised cells of the body. Stem cell research also involves complex ethical and legal considerations since they involve adult, foetal tissue and embryonic sources. This new book brings together leading research from throughout the world in this frontier field.
£173.24
Nova Science Publishers Inc Morphogenetic Developmental Programs: Stem Cells
Book Synopsis
£36.74
Nova Science Publishers Inc Stem Cells & Regenerative Medicine: Volume 7 --
Book Synopsis
£139.49
Nova Science Publishers Inc Stem Cell Research Advancements
Book Synopsis
£107.99
Nova Science Publishers Inc Stem Cell Therapy & Uses in Medical Treatment
Book Synopsis
£107.99
Nova Science Publishers Inc Tissue Engineering & the Musculoskeletal System:
Book SynopsisTissue engineering and regenerative medicine uses a combination of cells, scaffolding and bioreactive factors to treat a variety of pathological conditions and has become a treatment option for many adult diseases. In this book, the authors present current research from across the globe, in the study of the fundamentals, techniques and applications of tissue engineering. Topics discussed in this compilation include the characterization of liver organogenesis and foetal and adult stem/progenitor cells; in vitro biological activity of double and triple component system scaffolds in bone tissue engineering; stretching bioreactors for dynamic engineering of muscle tissues; adipose-derived stem cells and their application in tissue engineering; regenerative medicine and tissue engineering for congenital birth defects.
£159.74
World Scientific Publishing Co Pte Ltd Guide To Human Gene Therapy, A
Book SynopsisEver since the birth of molecular biology, the tantalizing possibility of treating disease at its genetic roots has become increasingly feasible. Gene therapy — though still in its infancy — remains one of the hottest areas of research in medicine. Its approach utilizes a gene transfer vehicle ('vector') to deliver therapeutic DNA or RNA to cells of the body in order to rectify the defect that is causing the disease. Successful therapies have been reported in humans in recent years such as cures in boys with severe immune deficiencies. Moreover, gene therapy strategies are being adapted in numerous biomedical laboratories to obtain novel treatments for a variety of diseases and to study basic biological aspects of disease. Correction of disease in animal studies, is steadily gaining ground, highlighting the immense potential of gene therapy in the medical profession.This book will cover topics that are at the forefront of biomedical research such as RNA interference, viral and non-viral gene transfer systems, treatment of hematological diseases and disorders of the central nervous system. Leading experts on the respective vector or disease will contribute the individual chapters and explain cutting-edge technologies. It also gives a broad overview of the most important gene transfer vectors and most extensively studied target diseases. This comprehensive guide is therefore a must-read for anyone in the biotechnology, biomedical or medical industries seeking to further their knowledge in the area of human gene therapy.
£45.60
World Scientific Publishing Co Pte Ltd Guide To Human Gene Therapy, A
Book SynopsisEver since the birth of molecular biology, the tantalizing possibility of treating disease at its genetic roots has become increasingly feasible. Gene therapy — though still in its infancy — remains one of the hottest areas of research in medicine. Its approach utilizes a gene transfer vehicle ('vector') to deliver therapeutic DNA or RNA to cells of the body in order to rectify the defect that is causing the disease. Successful therapies have been reported in humans in recent years such as cures in boys with severe immune deficiencies. Moreover, gene therapy strategies are being adapted in numerous biomedical laboratories to obtain novel treatments for a variety of diseases and to study basic biological aspects of disease. Correction of disease in animal studies, is steadily gaining ground, highlighting the immense potential of gene therapy in the medical profession.This book will cover topics that are at the forefront of biomedical research such as RNA interference, viral and non-viral gene transfer systems, treatment of hematological diseases and disorders of the central nervous system. Leading experts on the respective vector or disease will contribute the individual chapters and explain cutting-edge technologies. It also gives a broad overview of the most important gene transfer vectors and most extensively studied target diseases. This comprehensive guide is therefore a must-read for anyone in the biotechnology, biomedical or medical industries seeking to further their knowledge in the area of human gene therapy.Table of ContentsNon-Viral Vectors (S Sullivan); Adenoviral Vectors (A Baker); Retroviral Vectors and Integration Analysis (C von Kalle); Lentiviral Vectors (T VandenDriessche & M Chuah); Herpes Virus Vectors (J Glorioso); Adeno-Associated Viral (AAV) Vectors (N Muzyczka); Regulatory RNAs (Ribozymes, RNAi and miRNA) (A Lewin); Integrating Vectors (Transposon, Phage Integrase) (M Calos); Gene Correction Strategies/Zinc Fingers (M Porteus); Gene Switches (P Moullier); Gene Therapy for Disorders of the CNS (D Young); Hemoglobinopathies (A Srivastava); Severe Immune Deficiencies (A Aiuti); Hemophilia (R Herzog); Obesity and Diabetes (S Zolotukhin & C Wasserfall); Musculoskeletal Disorders (S Takeda); Cancer Gene Therapy (K Weigel-Van Aiken); Autoimmune Disorders (P Robbins); Lysosomal Storage Diseases (C Mah); Retinal Diseases (B Hauswirth); Pulmonary Diseases (T Flotte); Cardiovascular Diseases (B Byrne).
£117.00
